Revenue, last quarter
$2M
+149.9% vs same quarter last year
Net income
−$6.5M
−208.3% vs same quarter last year
EPS, diluted
−$0.52
−116.7% vs same quarter last year
Operating cash flow
−$2.3M
−58.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $3.6M | −$7.8M |
| FY24 | $2.7M | −$8.2M |
| FY23 | $2.5M | −$14.6M |
| FY22 | $2.7M | −$4.8M |
| FY21 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 84.2% | −219.4% | −218.5% |
| FY24 | 86.5% | −266.5% | −306.8% |
| FY23 | 87.7% | −270.9% | −594.6% |
| FY22 | 88.9% | −125.6% | −178% |
| FY21 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$6.5M |
| FY24 | −$6.1M |
| FY23 | −$6.7M |
| FY22 | −$2.3M |
| FY21 | - |
- Neuraxis
- Healthcare median
Show the numbers
| Year | Neuraxis | Healthcare median |
|---|---|---|
| FY25 | −218.5% | −30.6% |
| FY24 | −306.8% | −47% |
| FY23 | −594.6% | −58% |
| FY22 | −178% | −80.4% |
| FY21 | - | −71.9% |